ACE and hydrops fetalis: Most of the participants (53.8%) had HF with systolic dysfunction (left ventricular ejection fraction ≤ 40%) and were on recommended HF medications of beta blockers (92.3%), angiotensin-converting enzyme inhibitors (61.5%), angiotensin receptor blockers (23.1%), and diuretics (61.5%).